Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 9657473)

Published in Circulation on June 30, 1998

Authors

R A Cooper1, V J Plumb, A E Epstein, G N Kay, R E Ideker

Author Affiliations

1: Department of Medicine, The University of Alabama at Birmingham Medical Center, USA. rac@crml.uab.edu

Articles by these authors

Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol (2001) 3.65

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J (2001) 3.34

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation (2001) 3.13

Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation (1996) 2.67

Estimation of conduction velocity vector fields from epicardial mapping data. IEEE Trans Biomed Eng (1998) 2.59

ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27

Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation (1998) 2.25

Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation (1996) 2.19

AVID necessity. Pacing Clin Electrophysiol (1993) 2.03

Internal cardioversion of atrial fibrillation in sheep. Circulation (1993) 1.99

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation (1995) 1.94

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation (1996) 1.94

Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients. J Cardiovasc Electrophysiol (1993) 1.87

Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol (1999) 1.76

Mechanism of ventricular vulnerability to single premature stimuli in open-chest dogs. Circ Res (1988) 1.68

Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med (2000) 1.67

Unexpected ICD pulse generator failure due to electronic circuit damage caused by electrical overstress. Pacing Clin Electrophysiol (2001) 1.67

Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol (1997) 1.66

Retrograde coronary venous infusion of ethanol for ablation of canine ventricular myocardium. J Cardiovasc Electrophysiol (1998) 1.63

Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol (1983) 1.58

A QRS scoring system for assessing left ventricular function after myocardial infarction. N Engl J Med (1982) 1.55

Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Evidence for involvement of perinodal myocardium within the reentrant circuit. Circulation (1992) 1.54

Nonlinear changes of transmembrane potential during defibrillation shocks: role of Ca(2+) current. Circ Res (2000) 1.54

Responses of the transmembrane potential of myocardial cells during a shock. J Cardiovasc Electrophysiol (1995) 1.51

Association between ease of suppression of ventricular arrhythmia and survival. Circulation (1995) 1.48

Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability. Circulation (1986) 1.47

Stimulus-induced critical point. Mechanism for electrical initiation of reentry in normal canine myocardium. J Clin Invest (1989) 1.46

The management of atrial fibrillation. Am J Med (1996) 1.45

On the mechanism of ventricular defibrillation. Pacing Clin Electrophysiol (1997) 1.44

Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement. Circulation (1982) 1.44

Activation during ventricular defibrillation in open-chest dogs. Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks. J Clin Invest (1986) 1.42

Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation (1984) 1.41

Intermediate septal accessory pathways: electrocardiographic characteristics, electrophysiologic observations and their surgical implications. J Am Coll Cardiol (1991) 1.40

Why do some patients have high defibrillation thresholds at defibrillator implantation? Answers from basic research. Pacing Clin Electrophysiol (1994) 1.39

Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems? J Cardiovasc Electrophysiol (1999) 1.39

Invited letter concerning: amiodarone and quinidine for postoperative atrial arrhythmias. J Thorac Cardiovasc Surg (1990) 1.39

Continuous telemetry from a chronic canine model of sudden cardiac death. J Cardiovasc Electrophysiol (2000) 1.39

Radiofrequency ablation for treatment of primary atrial tachycardias. J Am Coll Cardiol (1993) 1.37

Fibrillation is more complex in the left ventricle than in the right ventricle. J Cardiovasc Electrophysiol (2000) 1.33

Virtual electrode effects in myocardial fibers. Biophys J (1994) 1.30

ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation (1998) 1.23

Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs. Circulation (2000) 1.23

Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc (2000) 1.21

Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs. Circ Res (1993) 1.20

Myocardial infarct size and location in relation to the coronary vascular bed at risk in man. Circulation (1981) 1.19

Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. Circulation (2000) 1.19

A quantitative framework for analyzing epicardial activation patterns during ventricular fibrillation. Ann Biomed Eng (1997) 1.19

Simultaneous optical mapping of transmembrane potential and intracellular calcium in myocyte cultures. J Cardiovasc Electrophysiol (2000) 1.19

Optical measurements of transmembrane potential changes during electric field stimulation of ventricular cells. Circ Res (1993) 1.17

Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. Circulation (1986) 1.16

Transmural activations and stimulus potentials in three-dimensional anisotropic canine myocardium. Circ Res (1988) 1.15

Combined automatic implantable cardioverter-defibrillator and pacemaker systems: implantation techniques and follow-up. J Am Coll Cardiol (1989) 1.14

Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators. Circulation (1999) 1.13

Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. Am J Cardiol (1982) 1.13

Development of an endocardial-epicardial gradient of activation rate during electrically induced, sustained ventricular fibrillation in dogs. Am J Cardiol (1985) 1.13

Influence of shock strength and timing on induction of ventricular arrhythmias in dogs. Am J Physiol (1988) 1.11

The potential gradient field created by epicardial defibrillation electrodes in dogs. Circulation (1986) 1.10

Intracoronary ethanol ablation for the treatment of recurrent sustained ventricular tachycardia. J Am Coll Cardiol (1992) 1.10

A new animal model of atrial flutter. J Am Coll Cardiol (1986) 1.09

The effect of maximum heart rate on oxygen kinetics and exercise performance at low and high workloads. Pacing Clin Electrophysiol (1998) 1.09

Three-dimensional potential gradient fields generated by intracardiac catheter and cutaneous patch electrodes. Circulation (1992) 1.08

Mechanism of ventricular defibrillation for near-defibrillation threshold shocks: a whole-heart optical mapping study in swine. Circulation (2001) 1.08

Epicardial activation after unsuccessful defibrillation shocks in dogs. Am J Physiol (1988) 1.08

The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter. Circulation (1995) 1.08

Conduction disturbances caused by high current density electric fields. Circ Res (1990) 1.06

Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction: retrospective study of patients with typical anterior and posterior infarcts. Circulation (1977) 1.06

Incidence, evolution, and spatial distribution of functional reentry during ventricular fibrillation in pigs. Circ Res (1999) 1.05

Periodic conductivity as a mechanism for cardiac stimulation and defibrillation. IEEE Trans Biomed Eng (1987) 1.05

Cellular characteristics of neoplastic angioendotheliosis. An immunohistological marker study of 6 cases. Virchows Arch A Pathol Anat Histopathol (1985) 1.05

Predictors of recurrent atrioventricular nodal reentry after selective slow pathway ablation. Am J Cardiol (1994) 1.05

Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. The Endotak Investigators. J Cardiovasc Electrophysiol (1995) 1.04

Demonstration of the mechanism of transient entrainment and interruption of ventricular tachycardia with rapid atrial pacing. J Am Coll Cardiol (1984) 1.04

Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation. Am J Cardiol (1988) 1.03

Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations. Arch Intern Med (1987) 1.03

Improvement of defibrillation efficacy and quantification of activation patterns during ventricular fibrillation in a canine heart failure model. Circulation (2001) 1.03

A quantitative measurement of spatial order in ventricular fibrillation. J Cardiovasc Electrophysiol (1993) 1.02

Temporary epicardial wire electrodes in the diagnosis and treatment of arrhythmias after open heart surgery. Am J Surg (1984) 1.02

Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular defibrillation. Circulation (1992) 1.02

Amiodarone lung: pathologic findings in clinically toxic patients. Hum Pathol (1987) 1.02

The effect of chemical ablation of the endocardium on ventricular fibrillation threshold. Circulation (1986) 1.01

Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts. Am J Cardiol (1983) 1.01

Cardiovascular preparticipation screening of competitive athletes: addendum: an addendum to a statement for health professionals from the Sudden Death Committee (Council on Clinical Cardiology) and the Congenital Cardiac Defects Committee (Council on Cardiovascular Disease in the Young), American Heart Association. Circulation (1998) 1.00